As stem-like cells have been shown to contribute to radioresistance [41], combined EGFR/Notch targeting in lung cancer cells bearing activating mutations in EGFR could offer a very powerful approach to reduce the radiation resistant populations. Here, EGFR is linked to lung cancer.